WASHINGTON, D.C. (WPVI) -- A popular group of drugs for type 2 diabetes is in the spotlight. The FDA has issued a new warning about their potential side effects. The agency has added a new warning to ...
(Reuters) - A class of diabetes drugs that include Merck & Co Inc's Januvia has been linked with severe joint pain, the U.S. Food and Drug Administration said on Friday. The FDA said it had identified ...
Linagliptin (trade name: Trajenta®) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results